💊 الأدوية من أ إلى ي 🧬 الأهداف 🛠 الأدوات 📚 الأدلة
جميع الأدوية تصنيفات الأدوية المجالات العلاجية الآثار الجانبية
الأدلة المسرد الجدول الزمني
المقارنات مسارات الأدوية عائلات الأدوية
🇺🇸 English 🇸🇦 العربية

Calcium Oxybate

CHEMBL4594393 Phase 4 معتمد Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
246.3 g/mol
LogP
—
Phase
4

A calcium-containing formulation of gamma-hydroxybutyrate (GHB), under investigation as a treatment for narcolepsy, a sleep disorder causing excessive daytime sleepiness and cataplexy. It works on GABA and GHB receptors in the brain to consolidate nighttime sleep. It has a lower sodium content compared to sodium oxybate, which may benefit patients on sodium-restricted diets.

الوزن الجزيئي

246,2700 g/mol

TPSA

121,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
O=C([O-])CCCO.O=C([O-])CCCO.[Ca+2]

                

                

                
                

                    
InChI

                    
InChI=1S/2C4H8O3.Ca/c2*5-3-1-2-4(6)7;/h2*5H,1-3H2,(H,6,7);/q;;+2/p-2

                

                

                

                    
                    

                        
Molecular Formula

                        
C8H14CaO6

                    

                    
                    

                        
HBD / HBA

                        
2 / 6

                    

                    
                    

                        
الروابط القابلة للدوران

                        
4

                    

                    
                    
                    

                        
الذرات الثقيلة

                        
15

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
الأسئلة الشائعة

                

                    
                    

                        
                        

                            
A calcium-containing formulation of gamma-hydroxybutyrate (GHB), under investigation as a treatment for narcolepsy, a sleep disorder causing excessive daytime sleepiness and cataplexy. It works on GABA and GHB receptors in the brain to consolidate nighttime sleep. It has a lower sodium content compared to sodium oxybate, which may benefit patients on sodium-restricted diets.

                        

                    

                    

                    

                    

                    

                    

                        
                        

                            
Yes, Calcium Oxybate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            



    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL4594393.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 6100372.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.




        


        
        
    


    



    
إخلاء المسؤولية الطبية

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.